4.8 Review

Chagas disease

Journal

LANCET
Volume 391, Issue 10115, Pages 82-94

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(17)31612-4

Keywords

-

Funding

  1. Ministerio de Economia y Competitividad
  2. Instituto de Salud Carlos III, Subdireccion General de Redes
  3. Network Biomedical Research on Tropical Diseases (RICET) [RD16/0027/0020]

Ask authors/readers for more resources

Chagas disease is an anthropozoonosis from the American continent that has spread from its original boundaries through migration. It is caused by the protozoan Trypanosoma cruzi, which was identified in the first decade of the 20th century. Once acute infection resolves, patients can develop chronic disease, which in up to 30-40% of cases is characterised by cardiomyopathy, arrhythmias, megaviscera, and, more rarely, polyneuropathy and stroke. Even after more than a century, many challenges remain unresolved, since epidemiological control and diagnostic, therapeutic, and prognostic methods must be improved. In particular, the efficacy and tolerability profile of therapeutic agents is far from ideal. Furthermore, the population affected is older and more complex (eg, immunosuppressed patients and patients with cancer). Nevertheless, in recent years, our knowledge of Chagas disease has expanded, and the international networking needed to change the course of this deadly disease during the 21st century has begun.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available